1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial
- The relevance of EU directive 2010/53/EU for living organ donation practice
- 2015
- Conditioning with sevoflurane in liver transplantation: results of a multicenter randomized controlled trial
- Dealing with public solicitation of organs from living donors
- 2014
- The combination of ET-DRI and recipient risk factors is predictive of graft failure after liver transplantation within the Eurotransplant region
- Long-term safety with everolimus-based regimen in de novo liver transplant recipients: 4-year results from the extension of H2304 study
- Absence of viable HCC in the native liver is an independent protective factor of tumor recurrence after liver transplantation
- 2013
- Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring
- Expansion of memory-type CD8⁺ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycin
- Anonymity and live donor transplantation